Richard S. Geary, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 3,360 shares at $75.05 ($252K) on 2025-11-03, disclosed to the SEC on 2025-11-07.
Scheduled sale ($252k) by EVP, Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.05 | 775 | $58K | 23.1% |
| 2 | $75.05 | 775 | $58K | 23.1% |
| 3 | $75.05 | 905 | $68K | 26.9% |
| 4 | $75.05 | 905 | $68K | 26.9% |
| Total | $75.05 avg | 3,360 | $252K | 100% |
| Filing → |
| IONS | SELL | 2025-10-01 | $7.6M | — | Filing → |
| IONS | SELL | 2025-09-04 | $504K | — | Filing → |
| IONS | SELL | 2025-08-06 | $429K | — | Filing → |